Compound Detail
CHEMBL5572601
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5572601 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | RAEQNTCTGLRWLL-MRXNPFEDSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
450.5
MW (Da)
2.10
ALogP
11
HBA
2
HBD
127.2
PSA (Ų)
0.41
QED
1
Ro5 Violations
8
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 8.52
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| CDK12/Cyclin K CHEMBL4106169 | IC50 | 8.52 | 8.52 | 3.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| CDK12/Cyclin K | IC50 | = | 3.0 | nM | 8.52 | Inhibition of recombinant human CDK12/Cyclin K using RNA Pol II-CTD as substrate... | 38061230 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 38061230 | 10.1016/j.ejmech.2023.116014 | CDK12/Cyclin K | 1 |
| 38061230 | 10.1016/j.ejmech.2023.116014 | SK-BR-3 | 1 |
| 38061230 | 10.1016/j.ejmech.2023.116014 | HCC1954 | 1 |
Data from ChEMBL 36 via Core Engine